This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the effects of taxanes as part of a combined or single‐agent therapy versus other agents or best supportive care as first‐ or second‐line treatment for advanced non‐small cell lung cancer (NSCLC).

A secondary objective is to assess different modes or schemes of administration of taxanes in patients with this disease.